DE60138192D1 - Verfahren zur quantifizierung der akt-protein-expression - Google Patents

Verfahren zur quantifizierung der akt-protein-expression

Info

Publication number
DE60138192D1
DE60138192D1 DE60138192T DE60138192T DE60138192D1 DE 60138192 D1 DE60138192 D1 DE 60138192D1 DE 60138192 T DE60138192 T DE 60138192T DE 60138192 T DE60138192 T DE 60138192T DE 60138192 D1 DE60138192 D1 DE 60138192D1
Authority
DE
Germany
Prior art keywords
proteins
quantitating
protein expression
quantification
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60138192T
Other languages
English (en)
Inventor
Sarah S Bacus
Andrei Gudkov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ventana Medical Systems Inc
University of Illinois
Original Assignee
Ventana Medical Systems Inc
University of Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ventana Medical Systems Inc, University of Illinois filed Critical Ventana Medical Systems Inc
Application granted granted Critical
Publication of DE60138192D1 publication Critical patent/DE60138192D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Toxicology (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE60138192T 2000-04-14 2001-04-16 Verfahren zur quantifizierung der akt-protein-expression Expired - Lifetime DE60138192D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19778000P 2000-04-14 2000-04-14
PCT/US2001/012288 WO2001079855A2 (en) 2000-04-14 2001-04-16 Method for quantification of akt protein expression

Publications (1)

Publication Number Publication Date
DE60138192D1 true DE60138192D1 (de) 2009-05-14

Family

ID=22730734

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60138192T Expired - Lifetime DE60138192D1 (de) 2000-04-14 2001-04-16 Verfahren zur quantifizierung der akt-protein-expression

Country Status (9)

Country Link
US (2) US20020015974A1 (de)
EP (1) EP1301794B1 (de)
JP (1) JP4317913B2 (de)
AT (1) ATE427494T1 (de)
AU (2) AU5352901A (de)
CA (1) CA2406443C (de)
DE (1) DE60138192D1 (de)
ES (1) ES2322888T3 (de)
WO (1) WO2001079855A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0218909D0 (en) * 2002-08-15 2002-09-25 Qinetiq Ltd Histological assessment
PL2574341T3 (pl) 2004-03-29 2017-09-29 University Of South Florida Efektywne leczenie guzów i raka fosforanem tricyrybiny
US8628931B2 (en) * 2005-10-18 2014-01-14 George Mason Intellectual Properties, Inc. mTOR pathway theranostic
EP3029461B1 (de) 2006-11-01 2017-12-20 Ventana Medical Systems, Inc. Haptene, haptenkonjugate, zusammensetzungen daraus und verfahren für ihre herstellung und verwendung
JP4795203B2 (ja) * 2006-11-13 2011-10-19 シスメックス株式会社 アンスラサイクリン系抗癌剤の感受性判定方法及びそのシステム
CA2687178C (en) 2007-05-23 2014-02-04 Ventana Medical Systems, Inc. Polymeric carriers for immunohistochemistry and in situ hybridization
WO2009015368A2 (en) * 2007-07-25 2009-01-29 Eisai R & D Management Co., Ltd. Multikinase inhibitors for use in the treatment of cancer
JP5564431B2 (ja) * 2007-10-29 2014-07-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 ゼアラレノンアナログ化合物ががんを処置する能力を予測する方法
US7837125B2 (en) * 2007-12-27 2010-11-23 Apple Inc. Methods and systems for encoding a magnetic stripe
WO2009149013A2 (en) 2008-06-05 2009-12-10 Ventana Medical Systems, Inc. Compositions comprising nanomaterials and method for using such compositions for histochemical processes
US8875886B2 (en) * 2008-08-25 2014-11-04 Apple Inc. Carrier card arrangement with removable envelope

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288477A (en) * 1991-09-27 1994-02-22 Becton, Dickinson And Company Method for prognosticating response to cancer therapy
US5846749A (en) * 1994-10-12 1998-12-08 The Regents Of The University Of California Quantitative measurement of tissue protein identified by immunohistochemistry and standardized protein determination
US6218521B1 (en) * 1997-07-17 2001-04-17 Ludwig Institute For Cancer Research Isolated nucleic acid molecules associated with gastric cancer and methods for diagnosing and treating gastric cancer
EP1247097B1 (de) * 2000-01-12 2004-07-21 Ventana Medical Systems, Inc. Verfahren zum nachweis der effektivität einer krebstherapie
US20020055478A1 (en) * 2000-04-12 2002-05-09 Mary Faris GTP-binding protein useful in treatment and detection of cancer

Also Published As

Publication number Publication date
JP4317913B2 (ja) 2009-08-19
WO2001079855A2 (en) 2001-10-25
CA2406443A1 (en) 2001-10-25
AU2001253529B2 (en) 2006-04-27
AU5352901A (en) 2001-10-30
ES2322888T3 (es) 2009-07-01
US20020015974A1 (en) 2002-02-07
WO2001079855A3 (en) 2003-02-06
ATE427494T1 (de) 2009-04-15
EP1301794A2 (de) 2003-04-16
JP2004512495A (ja) 2004-04-22
US20050106639A1 (en) 2005-05-19
CA2406443C (en) 2009-06-23
EP1301794B1 (de) 2009-04-01

Similar Documents

Publication Publication Date Title
WO2008021290A9 (en) Organ-specific proteins and methods of their use
ATE425266T1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
WO2008070865A3 (en) Materials and methods for efficient and accurate detection of analytes
BRPI0707645B8 (pt) métodos in vitro para detecção de câncer em um indivíduo e para avaliação de prognóstico de um indivíduo tendo, ou suspeito de ter, câncer ovariano
ATE230487T1 (de) Verfahren zur frühen diagnose von carcinomen
ATE222254T1 (de) Verwendung von einem metalloporphyrinkonjugat für den nachweis biologischer verbindungen
WO2005103698A3 (en) Methods and antibodies for nitrofuran detection
DE60228557D1 (de) Candida-nachweis
DE60129151D1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
WO2007024735A3 (en) Method and antibodies for detecting nitrofuran
DE60138192D1 (de) Verfahren zur quantifizierung der akt-protein-expression
WO2006004958A3 (en) Detection or measurement of antibodies to antigenic proteins in biological tissues or samples
NO20050130L (no) Bakteriell testmetode ved glykatert merket binding
BRPI0416270A (pt) método para detectar um analito em uma amostra, e, método e kit para detectar um anticorpo especìfico de uma amostra
WO2004077057A8 (en) Standard for immunohistochemistry, immunocytochemistry and molecular cytogenetics
CY1106349T1 (el) Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
ATE383418T1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
WO2002066982A8 (de) Analyse von modifizierungen und demodifizierungen von proteinen mit ubiquintin-verwandten proteinen mittels fret (fluorescence resonance energy transfer)
DE60012723D1 (de) Verfahren zur bestimmung von disaccharidasen
WO2007071250A3 (en) Method for detection of l523s expression in biological samples
DK1192469T3 (da) Assay
WO2004094989A3 (en) Methods of host cell protein analysis
DK1210606T3 (da) Bruskresorptionsassays
MX9606065A (es) Proteina fijadora de atp y acidos nucleicos con supuestas propiedades de helicasa y atpasa.
DK1423708T3 (da) Sammensætninger og fremgangsmåder til bestemmelser af AA4RP

Legal Events

Date Code Title Description
8364 No opposition during term of opposition